Shanghai Allist Pharmaceuticals Co., Ltd. (688578)
SSE
100.41
+1.98 (+2.01%)
Closed
Sep 18, 2026
Day's Range
98.60101.35
52 wk Range
78.82138.30
Financial Statements - 688578 - Shanghai Allist Pharmaceuticals Co., Ltd.
Revenue
5.18B▲ 45.8%
Net Income
2.18B▲ 53.1%Net Margin 42.2%
EBITDA
2.54B▲ 56.5%
Free Cash Flow
2.13B▲ 64.9%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 5.18B | 3.55B | 2.01B | 791M | 530.09M | 560.88K |
| Cost of Goods | 164.57M | 143.48M | 77.87M | 31.71M | 5.64M | 161.69K |
| Gross Profit | 5.02B | 3.41B | 1.94B | 759.28M | 524.44M | 399.19K |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | 2.48B | 1.53B | 569.92M | 46.27M | -49.52M | -338.57M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | - | - | - | - | - | - |
| Pre Tax Income | 2.54B | 1.61B | 656.22M | 125.99M | 18.27M | -310.51M |
| Income Tax | 355.83M | 188.67M | 12.04M | -4.52M | - | - |
| Net Income | 2.18B | 1.42B | 644.17M | 130.52M | 18.27M | -310.51M |
| EPS Basic | 4.86 | 3.18 | 1.43 | 0.29 | 0.04 | -0.84 |
| EPS Diluted | 4.86 | 3.18 | 1.43 | 0.29 | 0.04 | -0.84 |
| Basic Shares Outstanding | 450.43M | 449.63M | 450.47M | 450.07M | 456.86M | 369.66M |
| Diluted Shares Outstanding | 450.43M | 449.63M | 450.47M | 450.07M | 456.86M | 369.66M |
| Ebit | 2.54B | 1.61B | 656.38M | 126.32M | 18.87M | -309.37M |
| Ebitda | 2.54B | 1.62B | 672.37M | 119.89M | -2.96M | -305.76M |
| Net Income Continuous Operations | 2.18B | 1.42B | 644.17M | 130.52M | 18.27M | -310.51M |
| Minority Interests | - | - | - | - | - | - |
| Preferred Stock Dividends | 0 | 0 | 0 | 0 | 0 | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
